LEVODOPA/CARBIDOPA/ENTACAPONE TEVA õhukese polümeerikattega tablett Estonya - Estonca - Ravimiamet

levodopa/carbidopa/entacapone teva õhukese polümeerikattega tablett

teva pharma b.v. - levodopa+karbidopa+entakapoon - õhukese polümeerikattega tablett - 125mg+31,25mg+200mg 50tk; 125mg+31,25mg+200mg 150tk; 125mg+31,25mg+200mg 60tk; 125mg+31,25mg+200mg 98tk; 125mg+31,25mg+200mg 28tk; 125mg+31,25mg+200mg 130tk; 125mg+31,25mg+200mg 100tk; 125mg+31,25mg+200mg 30tk; 125mg+31,25mg+200mg 90tk; 125mg+31,25mg+200mg 10tk

LEVODOPA/CARBIDOPA/ENTACAPONE TEVA õhukese polümeerikattega tablett Estonya - Estonca - Ravimiamet

levodopa/carbidopa/entacapone teva õhukese polümeerikattega tablett

teva pharma b.v. - levodopa+karbidopa+entakapoon - õhukese polümeerikattega tablett - 75mg+18,75mg+200mg 250tk; 75mg+18,75mg+200mg 60tk; 75mg+18,75mg+200mg 150tk; 75mg+18,75mg+200mg 30tk; 75mg+18,75mg+200mg 10tk; 75mg+18,75mg+200mg 50tk; 75mg+18,75mg+200mg 90tk; 75mg+18,75mg+200mg 200tk; 75mg+18,75mg+200mg 100tk; 75mg+18,75mg+200mg 175tk; 75mg+18,75mg+200mg 98tk

LEVODOPA/CARBIDOPA/ENTACAPONE TEVA õhukese polümeerikattega tablett Estonya - Estonca - Ravimiamet

levodopa/carbidopa/entacapone teva õhukese polümeerikattega tablett

teva pharma b.v. - levodopa+karbidopa+entakapoon - õhukese polümeerikattega tablett - 50mg+12,5mg+200mg 50tk; 50mg+12,5mg+200mg 28tk; 50mg+12,5mg+200mg 30tk; 50mg+12,5mg+200mg 10tk; 50mg+12,5mg+200mg 60tk; 50mg+12,5mg+200mg 98tk; 50mg+12,5mg+200mg 90tk; 50mg+12,5mg+200mg 200tk; 50mg+12,5mg+200mg 250tk; 50mg+12,5mg+200mg 175tk; 50mg+12,5mg+200mg 100tk

Erysin Single Shot inj.ad us.vet süsteemulsioon Estonya - Estonca - Ravimiamet

erysin single shot inj.ad us.vet süsteemulsioon

bioveta a.s. - erysipelothrix rhusiopathiae, inaktiveeritud - süsteemulsioon - 100ml 1tk

AKLIEF kreem Estonya - Estonca - Ravimiamet

aklief kreem

galderma international - trifaroteen - kreem - 50mcg 1g 15g 1tk; 50mcg 1g 5g 1tk; 50mcg 1g 30g 1tk; 50mcg 1g 75g 1tk

Aspaveli Avrupa Birliği - Estonca - EMA (European Medicines Agency)

aspaveli

swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuuria, paroksüsmaalne - immunosupressandid - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.